146 related articles for article (PubMed ID: 10320044)
1. Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir.
Oon CJ; Chen WN; Lim N; Koh S; Lim GK; Leong AL; Tan GS
Antiviral Res; 1999 Apr; 41(3):113-8. PubMed ID: 10320044
[TBL] [Abstract][Full Text] [Related]
2. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.
Lee SY; Choi MS; Lee D; Lee JH; Koh KC; Paik SW; Yoo BC
J Korean Med Sci; 2005 Jun; 20(3):433-7. PubMed ID: 15953865
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
Wakil SM; Kazim SN; Khan LA; Raisuddin S; Parvez MK; Guptan RC; Thakur V; Hasnain SE; Sarin SK
J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
[TBL] [Abstract][Full Text] [Related]
5. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
Mutimer D; Pillay D; Cook P; Ratcliffe D; O'Donnell K; Dowling D; Shaw J; Elias E; Cane PA
J Infect Dis; 2000 Feb; 181(2):713-6. PubMed ID: 10669360
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
Bartholomew MM; Jansen RW; Jeffers LJ; Reddy KR; Johnson LC; Bunzendahl H; Condreay LD; Tzakis AG; Schiff ER; Brown NA
Lancet; 1997 Jan; 349(9044):20-2. PubMed ID: 8988118
[TBL] [Abstract][Full Text] [Related]
7. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.
Fernández-Galindo DA; Sánchez-Ávila F; Bobadilla-Morales L; Gómez-Quiróz P; Bueno-Topete M; Armendáriz-Borunda J; Sánchez-Orozco LV
J Med Virol; 2015 Jun; 87(6):985-92. PubMed ID: 25732900
[TBL] [Abstract][Full Text] [Related]
8. Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody.
Mesenas SJ; Chow WC; Zhao Y; Lim GK; Oon CJ; Ng HS
J Gastroenterol Hepatol; 2002 Feb; 17(2):148-52. PubMed ID: 11966944
[TBL] [Abstract][Full Text] [Related]
9. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus.
Torresi J
J Clin Virol; 2002 Aug; 25(2):97-106. PubMed ID: 12367644
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants.
Jardi R; Buti M; Rodriguez-Frias F; Cotrina M; Costa X; Pascual C; Esteban R; Guardia J
J Virol Methods; 1999 Dec; 83(1-2):181-7. PubMed ID: 10598095
[TBL] [Abstract][Full Text] [Related]
11. Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients.
Seta T; Yokosuka O; Imazeki F; Tagawa M; Saisho H
J Med Virol; 2000 Jan; 60(1):8-16. PubMed ID: 10568756
[TBL] [Abstract][Full Text] [Related]
12. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.
Chayama K; Suzuki Y; Kobayashi M; Kobayashi M; Tsubota A; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Murashima N; Ikeda K; Kumada H
Hepatology; 1998 Jun; 27(6):1711-6. PubMed ID: 9620347
[TBL] [Abstract][Full Text] [Related]
13. [A study on mutations of the overlapping hepatitis B virus surface and polymerase gene in patients with HBV reinfection after liver transplantations].
Song HL; Shen ZY; Wang J; Zheng WP; Wang ZL
Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):265-9. PubMed ID: 18423147
[TBL] [Abstract][Full Text] [Related]
14. Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.
Kazim SN; Sarin SK; Sharma BC; Khan LA; Hasnain SE
Intervirology; 2006; 49(3):152-60. PubMed ID: 16428891
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.
Allen MI; Deslauriers M; Andrews CW; Tipples GA; Walters KA; Tyrrell DL; Brown N; Condreay LD
Hepatology; 1998 Jun; 27(6):1670-7. PubMed ID: 9620341
[TBL] [Abstract][Full Text] [Related]
16. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
Neumann-Fraune M; Beggel B; Pfister H; Kaiser R; Verheyen J
J Med Virol; 2013 May; 85(5):775-9. PubMed ID: 23408582
[TBL] [Abstract][Full Text] [Related]
17. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.
Torresi J; Earnest-Silveira L; Civitico G; Walters TE; Lewin SR; Fyfe J; Locarnini SA; Manns M; Trautwein C; Bock TC
Virology; 2002 Jul; 299(1):88-99. PubMed ID: 12167344
[TBL] [Abstract][Full Text] [Related]
18. Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
Moriconi F; Colombatto P; Coco B; Ciccorossi P; Oliveri F; Flichman D; Maina AM; Sacco R; Bonino F; Brunetto MR
J Antimicrob Chemother; 2007 Aug; 60(2):341-9. PubMed ID: 17567633
[TBL] [Abstract][Full Text] [Related]
19. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
Suzuki F; Akuta N; Suzuki Y; Sezaki H; Arase Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Watahiki S; Kumada H
J Med Virol; 2006 Mar; 78(3):341-52. PubMed ID: 16419116
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.
Tatti KM; Korba BE; Stang HL; Peek S; Gerin JL; Tennant BC; Schinazi RF
Antiviral Res; 2002 Jul; 55(1):141-50. PubMed ID: 12076758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
